NCT06892431 2025-03-25
JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer
Shanghai JMT-Bio Inc.
Phase 2 Not yet recruiting
Shanghai JMT-Bio Inc.
EpicentRx, Inc.
EpicentRx, Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Martin-Luther-Universität Halle-Wittenberg
Innovation Pharmaceuticals, Inc.
GE Healthcare